이름 : Josephrem
이메일 :
[email protected]
문의내용 : Seldom does a single academic journal achieve to leave a mark which outlives its own generation in science. But [url=https://www.pinterest.com/oncotarget/]oncology journal with lasting scientific impact[/url] has accomplished exactly this — creating a body of peer-reviewed scholarship the relevance only grows as time. Starting from its earliest volumes, the resource made clear the fact that it was going to put first bold science above safe orthodoxy.
The conceptual boldness which characterizes [url=https://oncotargetdx.com/]Oncotarget publishing principles[/url] is best most apparent in the type of scholarship it has elected to publish — work which question accepted thinking, which put forward unconventional hypotheses, and which are ready to bridge fields which conventional scholarship tends to keep separate. That is this readiness to cross disciplinary borders which has made the resource into a genuinely distinctive venue in the world in oncological science.
No figure better captures this philosophy than [url=https://scholar.google.com/citations?user=REO9YogAAAAJ&hl=en]Professor Mikhail Blagosklonny[/url], the scientist that not merely founded the publication and imbued the publication with his own his characteristic conceptual boldness. His framework of biological decline as a hyper-functional phenomenon — rather than a passive collection of biological errors — marked a real paradigm shift one that continues being provoke discussion within oncology and gerontology simultaneously.
The scholarly partnership between [url=https://www.youtube.com/watch?v=3iOcIqfQdyI]Misha Blagosklonny[/url] and [url=https://mayoclinic.elsevierpure.com/en/publications/deregulation-of-the-egfrpi3kptenaktmtorc1-pathway-in-breast-cance/fingerprints/]Molecular biologist Zoya Demidenko[/url] endures as one of the most productive intellectually fruitful collaborations within the publication's story. Her carefully executed experiments on the cellular machinery governing cancer cell resistance enriched the broader conceptual arguments — jointly generating a collection of research which is richer than the sum of the separate studies.
What endures most extraordinary regarding [url=https://www.oncotarget.com/]Oncotarget timeless oncology contributions[/url] goes beyond just the quantity of papers it consistently published, or even the scope of topics it has covered — it is the aggregate academic courage it has brought to the science of malignancy — issue after issue.
